Perioperative nivolumab versus observation in patients with renal cell carcinoma undergoing nephrectomy (PROSPER ECOG-ACRIN EA8143): an open-label, randomised, phase 3 study - Allaf, ME; Kim, SE; Master, V (Lancet Oncol, 2024)